Global Local Anesthesia Drugs Market Size (2024 - 2029)

Local Anesthesia Drugs Market Analysis

The Global Local Anesthesia Drugs Market size is estimated at USD 5.09 billion in 2024, and is expected to reach USD 6.01 billion by 2029, growing at a CAGR of 3.40% during the forecast period (2024-2029).

The use of local anesthesia in treating patients infected with COVID-19 is in high demand due to its benefits and minimal risk of viral transmission. Additionally, as per an article published in October 2020, titled "Topical Lignocaine Anesthesia for Oropharyngeal Sampling for COVID-19," topical oropharyngeal lignocaine applications significantly increased comfort levels for the patient during oropharyngeal sampling for COVID-19 and did not affect the detection of SARS-CoV-2 in the upper airway. Thus, the study suggested that topical oropharyngeal lignocaine should be considered as a measure to reduce the viral inoculum sampling of a person suspected of being infected by COVID-19. Such studies are likely to boost the administration and use of local anesthesia drugs in treating COVID-19 patients globally.

Further, the growth of the local anesthesia drugs market is driven by various factors such as the rising number of surgeries, new approval of anesthetic drugs, and the growing use of local anesthetics in post-operative pain. The increasing number of surgeries was a major factor driving the market growth over the study period. For instance, as per the Plastic Surgery Statistics Report by the American Society of Plastic Surgeons, in 2020, the total number of cosmetic procedures performed were 2,314,720, including 211,067 procedures of liposuction in the US. As local anesthesia is widely used in such procedures, the growth in the number of such surgeries performed will propel the demand for anesthesia drugs. Furthermore, the development and approvals of novel local anesthesia drugs are proving to be a new revenue-generating resource for market players. For instance, in February 2021, PainPass launched the first Cannabidiol (CBD)/lidocaine product line targeting those with chronic pain and for numbing muscles externally.

However, the side effects of these drugs and strict regulatory framework are expected to restrain the market studied.

Local Anesthesia Drugs Industry Segmentation

As per the scope of the report, local anesthetics restrict the transmission of nerve impulses from the targeted region to the spinal cord. Local anesthetics are much safer to use, and they have fewer side effects than general anesthetics. The local anesthesia drugs market is segmented by drug type (bupivacaine, lidocaine, benzocaine, ropivacaine, prilocaine, chloroprocaine, and other drug types), mode of administration (injectable and surface anesthetic), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.